Petros Pechlivanoglou

Petros Pechlivanoglou, PhD, is a Senior Scientist at The Hospital for Sick Children (SickKids) Research Institute and an Associate Professor at the University of Toronto, Institute of Health Policy Management and Evaluation. He studied economics in his native country, Greece, econometrics at the University of Groningen, the Netherlands, and obtained a PhD in health econometrics from the same university.

He completed a post-doctoral fellowship at the University of Toronto, within the Toronto Health Economics and Technology Assessment (THETA) Collaborative where he focused on methodological aspects around the application of decision analysis in health-care policy.

Research

Dr. Pechlivanoglou’s research interests focus on methods and applications of decision analysis in health economics, bridging evidence synthesis, administrative data and decision analysis, and the application and extension of predictive models in health economics.

He has received funding from the Canadian Institute for Health Research, the Canadian Respiratory Research Network, and more recently, the Ontario Early Researcher Award to work on projects around the economics of pre-term birth prevention, the economic evaluation of oncology interventions in children and adolescents, the use of decision analysis in paediatric clinical trial design, and the economic impact of COPD in adults.

Education

• 2013–2015: Postdoctoral Fellow, Leslie Dan Faculty of Pharmacy, University of Toronto, Canada  
• 2007–2012: PhD, in Pharmacoeconomics, Unit of Pharmacoepidemiology and Pharmacoeconomics, Faculty of Pharmacy, University of Groningen, The Netherlands 
• 2005–2007: M.Sc., in Econometrics, Faculty of Economics, University of Groningen, Groningen, The Netherlands
• 2001–2005: B.Sc., in Economics, Faculty of Economic Sciences, University of Macedonia, Thessaloniki, Greece

Experience

• 2022–Present: Senior Scientist. The Hospital for Sick Children, Toronto, ON
• 2022–Present: Associate Professor. Institute of Health, Policy Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, ON
• 2020–Present: ICES Adjunct Scientist. Cancer Research Program, ICES, University of Toronto, Toronto, ON 
• 2016–2022: Assistant Professor. Institute of Health, Policy Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, ON 
• 2015–2022: Scientist. The Hospital for Sick Children, Toronto, ON 
• 2013–2015: Health Economist. Toronto Health Economics and Technology Assessment (THETA) Collaborative Toronto, ON 
• 2010–2012: Assistant in Training (AIO). Unit of Pharmacoepidemiology and Pharmacoeconomics, University of Groningen, Groningen, The Netherlands 
• 2007–2010: Research Associate. Unit of Pharmacoepidemiology and Pharmacoeconomics, University of Groningen, Groningen, The Netherlands 

Achievements

• 2019: The Nancy E.T. Fahrner Award – $3,000 (CAD) The Hospital for Sick Children, University of Toronto
• 2019: Member of Health Economics Advisory Council, Canadian Agency for Drugs and Technologies in Health
• 2019: Editorial board: Medical Decision Making Journal
• 2019–2024: Ontario Early Researcher Award – $150,000 (CAD) – Government of Ontario
• 2017–2018: Greek Diaspora Fellowship – 8,000 (Euros) –The Stavros Niarchos Foundation, Greece
• 2007–2010: Dutch Bursary Ph.D. Scholarship – 51,000 (Euros) – Groningen University, The Netherlands

1. Furzer J, Gupta S, Nathan PC, Schlechter T, Pole JD, Krueger J, Pechlivanoglou P. Cost-effectiveness of Tisagenlecleucel vs Standard Care in High-risk Relapsed Pediatric Acute Lymphoblastic Leukemia in Canada. JAMA Oncology. 2020 Jan. [Epub ahead of print]. 
2. Tessier L, Furzer J, Hodgson D, Cotton C, Nathan PC, Gupta S, Pechlivanoglou P. Cost-Utility of Early Breast Cancer Surveillance in Survivors of Thoracic Radiation-Treated Adolescent Hodgkin’s Lymphoma. Journal of the National Cancer Institute. 2020 Jan 1; 112(1):63-70.
3. Krijkamp EM, Alarid-Escudero F, Enns EA, Jalal HJ, Hunink MGM, Pechlivanoglou P. (2018). Microsimulation modeling for health decision sciences using R: A tutorial. Medical Decision Making. Apr 2018; 38(3):400-422.
4. Pechlivanoglou P, Abrahamyan L, MacKeigan L, Consiglio GP, Dolovich L, Li P, Cadarette SM, Rac VE, Shin J, Krahn M. Factors affecting the delivery of community pharmacist-led medication reviews: Evidence from the MedsCheck Annual service in Ontario. BMC Health Serv Res. Nov 2016; 16(1):666.
5. Pechlivanoglou P, Wieringa JE, de Jager T, Postma MJ. (2015). The effect of financial and educational incentives on rational prescribing. A state-space approach. Health Econ. Apr 2015; 24(4):439-53.